Lowest-Rated StocksLowest-RatedNASDAQ:DOCS Doximity (DOCS) Stock Price, News & Analysis → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free DOCS Stock Alerts $27.73 -0.02 (-0.07%) (As of 05/31/2024 ET) Add Compare Share Share Today's Range$27.50▼$28.3250-Day Range$23.00▼$28.9752-Week Range$19.71▼$36.29Volume1.54 million shsAverage Volume2.12 million shsMarket Capitalization$5.17 billionP/E Ratio38.51Dividend YieldN/APrice Target$28.73 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Get Doximity alerts: Email Address Doximity MarketRank™ Stock AnalysisAnalyst RatingHold2.13 Rating ScoreUpside/Downside3.6% Upside$28.73 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews Sentiment0.37Based on 12 Articles This WeekInsider TradingSelling Shares$171,250 Sold Last QuarterProj. Earnings Growth9.46%From $0.74 to $0.81 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.55 out of 5 starsMedical Sector496th out of 924 stocksCustom Computer Programming Services Industry14th out of 25 stocks 2.1 Analyst's Opinion Consensus RatingDoximity has received a consensus rating of Hold. The company's average rating score is 2.13, and is based on 3 buy ratings, 11 hold ratings, and 1 sell rating.Amount of Analyst CoverageDoximity has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Doximity's stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for DOCS. Previous Next 0.0 Dividend Strength Dividend YieldDoximity does not currently pay a dividend.Dividend GrowthDoximity does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DOCS. Previous Next 2.4 News and Social Media Coverage News SentimentDoximity has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.76 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 12 news articles for Doximity this week, compared to 6 articles on an average week.Search Interest32 people have searched for DOCS on MarketBeat in the last 30 days. This is an increase of 967% compared to the previous 30 days.MarketBeat FollowsOnly 8 people have added Doximity to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $171,250.00 in company stock.Percentage Held by Insiders39.40% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions87.19% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Doximity's insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Doximity are expected to grow by 9.46% in the coming year, from $0.74 to $0.81 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Doximity is 38.51, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 127.59.Price to Earnings Ratio vs. SectorThe P/E ratio of Doximity is 38.51, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 112.93.Price to Earnings Growth RatioDoximity has a PEG Ratio of 5.23. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDoximity has a P/B Ratio of 5.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Doximity's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. About Doximity Stock (NASDAQ:DOCS)Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.Read More DOCS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DOCS Stock News HeadlinesMay 28, 2024 | marketbeat.comDoximity is the Facebook and LinkedIn of the Medical CommunityDoximity stock is surging as analysts and investors are taking note of the cloud-based digital platform's strong revenue and earnings growthMay 22, 2024 | marketbeat.comDoximity is the Facebook and LinkedIn of the Medical CommunityDoximity Inc. NASDAQ: DOCS is a social networking platform exclusively designed for U.S. healthcare professionals. It's a cross between Meta Platforms Inc. NASDAQ: META owned Facebook and Microsoft Co. NASDAQ: MSFT owned LinkedIn.May 18, 2024 | insidertrades.comDoximity, Inc. (NASDAQ:DOCS) Insider Craig Overpeck Sells 1,500 SharesMay 31 at 10:45 PM | prnewswire.comDOXIMITY SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Doximity, Inc. - DOCSMay 31 at 6:31 PM | prnewswire.comClass Action Announcement for Doximity, Inc. (DOCS): Kessler Topaz Meltzer & Check, LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Doximity, Inc.May 31 at 10:35 AM | prnewswire.comDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DoximityMay 30 at 4:56 PM | prnewswire.comROSEN, A LONGSTANDING LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCSMay 30 at 4:01 PM | businesswire.comDoximity to Present at the William Blair 44th Annual Growth Stock ConferenceMay 30 at 4:00 PM | prnewswire.comDOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud LawsuitMay 30 at 2:31 PM | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Doximity, Inc. - DOCSMay 28, 2024 | markets.businessinsider.comIMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the FirmMay 27, 2024 | businesswire.comNYSE: DOCS: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Class Action Lawsuit Against Doximity, Inc.May 26, 2024 | finance.yahoo.comDoximity Full Year 2024 Earnings: EPS Beats ExpectationsMay 25, 2024 | markets.businessinsider.comDEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the FirmMay 24, 2024 | prnewswire.comDOXIMITY SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Doximity, Inc. - DOCSMay 24, 2024 | prnewswire.comIMPORTANT INVESTOR ALERT: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the FirmMay 23, 2024 | prnewswire.comDOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud LawsuitMay 23, 2024 | businesswire.comDoximity Releases New Study on Physician Compensation, Overwork, and ShortageMay 22, 2024 | prnewswire.comROSEN, LEADING INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCSMay 21, 2024 | businesswire.comDOCS INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCSMay 21, 2024 | prnewswire.comDOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud LawsuitMay 20, 2024 | finance.yahoo.comCompany News for May 20, 2024May 20, 2024 | prnewswire.comDoximity, Inc. (DOCS) Investors: June 17, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLPMay 20, 2024 | markets.businessinsider.comDoximity’s Stock Outperforms with Strong Q4 Results and Positive FY2025 OutlookMay 19, 2024 | stockhouse.comIMMINENT DOCS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Doximity, Inc. Investors to Join the Class Action Lawsuit!See More Headlines Receive DOCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/09/2021Today6/02/2024Next Earnings (Estimated)8/13/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Custom computer programming services Sub-IndustryN/A Current SymbolNASDAQ:DOCS CUSIPN/A CIK1516513 Webwww.doximity.com Phone650-549-4330FaxN/AEmployees977Year FoundedN/APrice Target and Rating Average Stock Price Target$28.73 High Stock Price Target$33.00 Low Stock Price Target$23.00 Potential Upside/Downside+3.6%Consensus RatingHold Rating Score (0-4)2.13 Research Coverage15 Analysts Profitability EPS (Most Recent Fiscal Year)$0.72 Trailing P/E Ratio38.51 Forward P/E Ratio37.47 P/E Growth5.23Net Income$147.58 million Net Margins31.04% Pretax Margin38.96% Return on Equity17.44% Return on Assets14.85% Debt Debt-to-Equity RatioN/A Current Ratio6.20 Quick Ratio6.20 Sales & Book Value Annual Sales$475.42 million Price / Sales10.88 Cash Flow$0.92 per share Price / Cash Flow30.06 Book Value$4.83 per share Price / Book5.74Miscellaneous Outstanding Shares186,550,000Free Float113,052,000Market Cap$5.17 billion OptionableNot Optionable Beta1.18 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Jeffrey A. Tangney (Age 51)Co-Founder, CEO & Chairperson Comp: $243.73kDr. Nate Gross M.D. (Age 40)Co-Founder & Chief Strategy Officer Comp: $455.54kMs. Anna Bryson (Age 34)Chief Financial Officer Comp: $453.71kMs. Jennifer W. Chaloemtiarana (Age 56)General Counsel & Corporate Secretary Comp: $504.04kMr. Paul Jorgensen (Age 53)Chief Revenue Officer Comp: $455.13kMs. Shari BuckCo-founder and SVP People & OpsMr. Jey BalachandranChief Technology OfficerMr. Perry Scott GoldHead of Investor RelationsJim RivasHead of Corporate CommunicationsMr. Bruno MirandaSenior VP of EngineeringMore ExecutivesKey CompetitorsSmartsheetNYSE:SMARPegasystemsNASDAQ:PEGAFive9NASDAQ:FIVNAvalaraNYSE:AVLRTeladoc HealthNYSE:TDOCView All CompetitorsInsiders & InstitutionsSwedbank ABBought 3,406,670 shares on 5/21/2024Ownership: 1.826%LRI Investments LLCBought 1,000 shares on 5/21/2024Ownership: 0.001%Virtu Financial LLCBought 8,295 shares on 5/20/2024Ownership: 0.004%Comerica BankBought 2,480 shares on 5/17/2024Ownership: 0.034%iA Global Asset Management Inc.Bought 7,208 shares on 5/17/2024Ownership: 0.018%View All Insider TransactionsView All Institutional Transactions DOCS Stock Analysis - Frequently Asked Questions Should I buy or sell Doximity stock right now? 15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Doximity in the last twelve months. There are currently 1 sell rating, 11 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" DOCS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DOCS, but not buy additional shares or sell existing shares. View DOCS analyst ratings or view top-rated stocks. What is Doximity's stock price target for 2024? 15 analysts have issued 1-year price objectives for Doximity's shares. Their DOCS share price targets range from $23.00 to $33.00. On average, they predict the company's share price to reach $28.73 in the next year. This suggests a possible upside of 3.6% from the stock's current price. View analysts price targets for DOCS or view top-rated stocks among Wall Street analysts. How have DOCS shares performed in 2024? Doximity's stock was trading at $28.04 at the beginning of the year. Since then, DOCS stock has decreased by 1.1% and is now trading at $27.73. View the best growth stocks for 2024 here. When is Doximity's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024. View our DOCS earnings forecast. How were Doximity's earnings last quarter? Doximity, Inc. (NASDAQ:DOCS) released its quarterly earnings results on Tuesday, November, 9th. The company reported $0.19 EPS for the quarter, topping analysts' consensus estimates of $0.06 by $0.13. The business earned $79.35 million during the quarter, compared to analysts' expectations of $73.60 million. Doximity had a trailing twelve-month return on equity of 17.44% and a net margin of 31.04%. What ETFs hold Doximity's stock? ETFs with the largest weight of Doximity (NASDAQ:DOCS) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Jacob Forward ETF (JFWD), Janus Henderson Small Cap Growth Alpha ETF (JSML), Fidelity Digital Health ETF (FDHT), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Renaissance IPO ETF (IPO), Pacer US Large Cap Cash Cows Growth Leaders ETF (COWG) and Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD). What guidance has Doximity issued on next quarter's earnings? Doximity updated its first quarter 2025 earnings guidance on Thursday, May, 16th. The company provided EPS guidance of for the period. The company issued revenue guidance of $119.5 million-$120.5 million, compared to the consensus revenue estimate of $119.2 million. When did Doximity IPO? Doximity (DOCS) raised $501 million in an initial public offering on Thursday, June 24th 2021. The company issued 23,300,000 shares at a price of $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities served as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers. Who are Doximity's major shareholders? Doximity's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (5.77%), Baillie Gifford & Co. (3.33%), William Blair Investment Management LLC (2.96%), Clearbridge Investments LLC (2.93%), Swedbank AB (1.83%) and Janus Henderson Group PLC (1.33%). Insiders that own company stock include Anna Bryson, Craig Overpeck, Gilbert H Kliman, Interwest Partners X Lp, Joseph B Kleine, Kevin Spain, Kira Scherer Wampler, Paul W Jorgensen and Timothy S Cabral. View institutional ownership trends. How do I buy shares of Doximity? Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:DOCS) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaHow Biden has already won 2024Porter & CompanyThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Doximity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.